OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Mass Spectrometry for Neurobiomarker Discovery: The Relevance of Post-Translational Modifications
Rita Azevedo, Chloé Jacquemin, Nicolas Villain, et al.
Cells (2022) Vol. 11, Iss. 8, pp. 1279-1279
Open Access | Times Cited: 26

Showing 1-25 of 26 citing articles:

Methods to Discover and Validate Biofluid-Based Biomarkers in Neurodegenerative Dementias
Charlotte E. Teunissen, Leighann Kimble, Sherif Bayoumy, et al.
Molecular & Cellular Proteomics (2023) Vol. 22, Iss. 10, pp. 100629-100629
Open Access | Times Cited: 22

Tau protein profiling in tauopathies: a human brain study
Juan Lantero Rodrı́guez, Elena Camporesi, Laia Montoliu‐Gaya, et al.
Molecular Neurodegeneration (2024) Vol. 19, Iss. 1
Open Access | Times Cited: 10

Advance computational tools for multiomics data learning
Sheikh Mansoor, Saira Hamid, Thai Thanh Tuan, et al.
Biotechnology Advances (2024) Vol. 77, pp. 108447-108447
Closed Access | Times Cited: 8

The omics era: a nexus of untapped potential for Mendelian chromatinopathies
Aileen A. Nava, Valerie A. Arboleda
Human Genetics (2023) Vol. 143, Iss. 4, pp. 475-495
Open Access | Times Cited: 14

Protein Oxidative Modifications in Neurodegenerative Diseases: From Advances in Detection and Modelling to Their Use as Disease Biomarkers
Sandra I. Anjo, Zhicheng He, Zohaib Hussain, et al.
Antioxidants (2024) Vol. 13, Iss. 6, pp. 681-681
Open Access | Times Cited: 5

Cerebrospinal Fluid Phosphoproteome Characterization Using Titanium Dioxide Enrichment and High-Resolution LC-MS/MS
Elena Anaya‐Cubero, Adriana Cortés, Mercedes Lachén‐Montes, et al.
Methods in molecular biology (2025), pp. 77-87
Closed Access

How can we modulate aging through nutrition and physical exercise? An epigenetic approach
Ana Teresa Rajado, Nádia Silva, Filipa Esteves, et al.
Aging (2023)
Open Access | Times Cited: 11

Protein modification in neurodegenerative diseases
Shahin Ramazi, Maedeh Dadzadi, Mona Darvazi, et al.
MedComm (2024) Vol. 5, Iss. 8
Open Access | Times Cited: 4

Posttranslational Modifications ofα-Synuclein, Their Therapeutic Potential, and Crosstalk in Health and Neurodegenerative Diseases
Kambiz Hassanzadeh, Jun Liu, Santhosh Chandar Maddila, et al.
Pharmacological Reviews (2024) Vol. 76, Iss. 6, pp. 1254-1290
Closed Access | Times Cited: 4

Cerebellar Pathology in Forensic and Clinical Neuroscience
Azhagu Madhavan Sivalingam, Darshitha D Sureshkumar
Ageing Research Reviews (2025), pp. 102697-102697
Closed Access

Identifying individuals using proteomics: are we there yet?
Ivo Fierro-Monti, James C. Wright, Jyoti S. Choudhary, et al.
Frontiers in Molecular Biosciences (2022) Vol. 9
Open Access | Times Cited: 13

A Quantitative LC-MS/MS Method for Distinguishing the Tau Protein Forms Phosphorylated and Nonphosphorylated at Serine-396
Anne‐Marie Jacobsen, Nico C. van de Merbel, Dorte Kornerup Ditlevsen, et al.
Journal of the American Society for Mass Spectrometry (2023) Vol. 34, Iss. 3, pp. 441-451
Closed Access | Times Cited: 7

Biochemical approaches to assess the impact of post-translational modifications on pathogenic tau conformations using recombinant protein
Mohammed M. Alhadidy, Nicholas M. Kanaan
Biochemical Society Transactions (2024) Vol. 52, Iss. 1, pp. 301-318
Open Access | Times Cited: 2

Post-Translational Variants of Major Proteins in Amyotrophic Lateral Sclerosis Provide New Insights into the Pathophysiology of the Disease
Léa Bedja-Iacona, Élodie Richard, Sylviane Marouillat, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 16, pp. 8664-8664
Open Access | Times Cited: 2

Targeting amyloid proteins for clinical diagnosis of neurodegenerative diseases
Shenqing Zhang, Hui Dong, Jiang Bian, et al.
Fundamental Research (2022) Vol. 3, Iss. 4, pp. 505-519
Open Access | Times Cited: 12

Site-Specific Phospho-Tau Aggregation-Based Biomarker Discovery for AD Diagnosis and Differentiation
Ling Wu, Nailya Gilyazova, John F. Ervin, et al.
ACS Chemical Neuroscience (2022) Vol. 13, Iss. 23, pp. 3281-3290
Closed Access | Times Cited: 10

UniSpec: Deep Learning for Predicting the Full Range of Peptide Fragment Ion Series to Enhance the Proteomics Data Analysis Workflow
Joel Lapin, Xinjian Yan, Qian Dong
Analytical Chemistry (2024)
Closed Access | Times Cited: 1

From use of omics to systems biology: Identifying therapeutic targets for amyotrophic lateral sclerosis
Lydia M. Castelli, Rosario Vasta, Scott P. Allen, et al.
International review of neurobiology (2024), pp. 209-268
Closed Access | Times Cited: 1

The Application of Analytical Techniques to Alpha-Synuclein in Parkinson’s Disease
Olatayo Adedayo Olahanmi
American Journal of Analytical Chemistry (2024) Vol. 15, Iss. 09, pp. 269-285
Open Access

Evaluation of SP3 for antibody-free quantification of tau in CSF mimic and brain by mass spectrometry
Chloé Jacquemin, Nicolas Villain, Rita Azevedo, et al.
European Journal of Mass Spectrometry (2024) Vol. 30, Iss. 1, pp. 65-75
Closed Access

Recent progress in biomarkers for neurodegenerative disorders
Karishma Vivek Kathpalia, Margaret Gyaawah Duodu, Ritu Raj, et al.
Elsevier eBooks (2024), pp. 423-436
Closed Access

Novel post-translational modifications in cancer
Dongling Li, Q Cai, Li Li, et al.
ONCOLOGIE (2024)
Closed Access

Mass Spectrometry-Based Methods in CNS Drug Discovery
Gonzalo Blasco, Rudy Schreiber, Daan van Kruining
(2024), pp. 87-115
Closed Access

Page 1 - Next Page

Scroll to top